glp-1 agonist fda approval Comparing Ozempic, Wegovy and Other Drugs GLP-1 Agonists: A Comprehensive Overview
Description
Fixed-effects models were applied under the assumption of a shared underlying effect size across datasets, while random-effects models accounted for potential heterogeneity among studies
Insurance coverage has been an issue
doi: 10.1056/NEJMoa2501006 91 ParabPChaudharyPMukhtarSMoradiAKodaliAOkoyeCet al
18 An even greater weight reduction of 9.6% was achieved with a higher dose of 2.4 mg weekly over 68 weeks in a trial in adults with overweight or obesity and diabetes
doi:10.1177/1091581809337737 37
What Now
